Journal article
Niacin in cardiovascular disease: recent preclinical and clinical developments.
- Abstract:
-
Niacin has been used for more than 50 years in the treatment of cardiovascular disease, although its use has largely been superseded by better-tolerated lipid-modulating interventions. There has been a renewed interest in the HDL-cholesterol raising properties of niacin, with the appreciation that substantial cardiovascular risk remains despite effective treatment of LDL-cholesterol. This coincides with increasing evidence that the complex functional properties of HDL are not well reflected b...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Arteriosclerosis, thrombosis, and vascular biology
- Volume:
- 32
- Issue:
- 3
- Pages:
- 582-588
- Publication date:
- 2012-03-01
- DOI:
- EISSN:
-
1524-4636
- ISSN:
-
1079-5642
- Source identifiers:
-
222353
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:222353
- UUID:
-
uuid:571e74d1-edb2-4f4f-90e7-aafa2ba0b42e
- Local pid:
- pubs:222353
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2012
If you are the owner of this record, you can report an update to it here: Report update to this record